Prophylactic and therapeutic potential of selected immunomodulatory agents from Ayurveda against coronaviruses amidst the current formidable scenario: an in silico analysis

References

• Abdelli, I., Hassani, F., BekkelBrikci, S., & Ghalem, S. (2021). In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria. Journal of Biomolecular Structure and Dynamics, 39(9), 3263–3276.
   PubMed Web of Science ®Google Scholar
• Acharya, Y., & Sayed, A. (2020). Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: A narrative review. Therapeutic Advances in Infectious Disease, 7, 1–14. https://doi.org/10.1177/2049936120947517
   Web of Science ®Google Scholar
• Acter, T., Uddin, N., Das, J., Akhter, A., Choudhury, T. R., & Kim, S. (2020). Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: A global health emergency. Science of the Total Environment, 730, 138996. https://doi.org/10.1016/j.scitotenv.2020.138996
   Google Scholar
• Ahmad, R. (2015). Anticancer potential of medicinal plants Withania somnifera, Tinospora cordifolia and Curcuma longa: A review. World Research Journal of Medicinal & Aromatic Plants, 3(1), 2278–9863.
   Google Scholar
• Ahmad, R. (2019). Steroidal glycoalkaloids from Solanum nigrum target cytoskeletal proteins: An in silico analysis. PeerJ, 7, e6012. https://doi.org/10.7717/peerj.6012
   PubMed Web of Science ®Google Scholar
• Ahmad, R., Khan, M. A., Srivastava, A. N., Gupta, A., Srivastava, A., Jafri, T. R., Siddiqui, Z., Chaubey, S., Khan, T., & Srivastava, A. K. (2020). Anticancer potential of dietary natural products: A comprehensive review. Anti-Cancer Agents in Medicinal Chemistry, 20(2), 122–236. https://doi.org/10.2174/1871520619666191015103712
   PubMed Web of Science ®Google Scholar
• Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020). Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies. Viruses, 12(3), 254. https://doi.org/10.3390/v12030254
   PubMed Web of Science ®Google Scholar
• Aier, I., Varadwaj, P. K., & Raj, U. (2016). Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. Scientific Reports, 6(1), 1. https://doi.org/10.1038/srep34984
   PubMedGoogle Scholar
• Al-Bari, M. A. A. (2017). Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacology Research & Perspectives, 5(1), e00293. https://doi.org/10.1002/prp2.293
   PubMedGoogle Scholar
• Albohy, A., Zahran, E. M., Abdelmohsen, U. R., Salem, M. A., Al-Warhi, T., Al-Sanea, M. M., Abelyan, N., Khalil, H. E., Desoukey, S. Y., Fouad, M. A., & Kamel, M. S. (2020). Multitarget in silico studies of Ocimummen thiifolium, family Lamiaceae against SARS-CoV-2 supported by molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 30, 1–1.
   Google Scholar
• Aniyery, R. B., Sharma, A., & Gupta, A. (2015). Molecular docking studies and in silico pharmacokinetic property study of synthesized organotin complex of (1r, 2s, 5r)-2-isopropyl-5-methylcyclohexanol. Journal of Chemical and Pharmaceutical Sciences, 9(4), 2656–2663.
   Google Scholar
• Báez-Santos, Y. M., John, S. E. S., & Mesecar, A. D. (2015). The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antiviral Research, 115, 21–38. https://doi.org/10.1016/j.antiviral.2014.12.015
   PubMed Web of Science ®Google Scholar
• Balkrishna, A., Pokhrel, S., Singh, H., Joshi, M., Mulay, V. P., Haldar, S. & Varshney, A. (2021). Withanone from Withania somnifera attenuates SARS-CoV-2 RBD and host ACE2 Interactions to rescue Spike protein induced pathologies in humanized zebrafish model. Drug Design, Development and Therapy, 15, 1111–1133. https://doi.org/10.2147/DDDT.S292805
   Google Scholar
• Belouzard, S., Millet, J. K., Licitra, B. N., & Whittaker, G. R. (2012). Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses, 4(6), 1011–1033. https://doi.org/10.3390/v4061011
   PubMed Web of Science ®Google Scholar
• Bloom, D. E., Canning, D., Kotschy, R., Prettner, K., Schünemann, J. J. (2019). Health and economic growth: Reconciling the micro and macro evidence. National Bureau of Economic Research.
   Google Scholar
• Bloom, D. E., & Cadarette, D. (2019). Infectious disease threats in the twenty-first century: Strengthening the global response. Frontiers in Immunology, 10, 549. https://doi.org/10.3389/fimmu.2019.00549
   PubMed Web of Science ®Google Scholar
• Borquaye, L. S., Gasu, E. N., Ampomah, G. B., Kyei, L. K., Amarh, M. A., Mensah, C. N., Nartey, D., Commodore, M., Adomako, A. K., Acheampong, P., Mensah, J. O., Mormor, D. B., & Aboagye, C. I. (2020). Alkaloids from Cryptolepiss anguinolenta as potential inhibitors of SARS-CoV-2 viral proteins: An in silico study. BioMed Research International,1–14. https://doi.org/10.1155/2020/5324560
   Google Scholar
• Borse, S., Joshi, M., Saggam, A., Bhat, V., Walia, S., Marathe, A., Sagar, S., Chavan-Gautam, P., Girme, A., Hingorani, L., & Tillu, G. (2021). Ayurveda botanicals in COVID-19 management: An in silico multi-target approach. PLoS One, 16(6), e0248479. https://doi.org/10.1371/journal.pone.0248479
   Google Scholar
• Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, evaluation and treatment coronavirus (COVID-19). InStatpearls [Internet]. StatPearls Publishing.
   Google Scholar
• Chen, H., & Du, Q. (2020). Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection. https://doi.org/10.20944/preprints202001.0358.v3
   Google Scholar
• Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Chen, Y., Liu, Q., & Guo, D. (2020). Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology, 92(4), 418–423. https://doi.org/10.1002/jmv.25681
   PubMed Web of Science ®Google Scholar
• Cheng, F., Li, W., Liu, G., & Tang, Y. (2013). In silico ADMET prediction: Recent advances, current challenges and future trends. Current Topics in Medicinal Chemistry, 13(11), 1273–1289. https://doi.org/10.2174/15680266113139990033
   PubMed Web of Science ®Google Scholar
• Cherrak, S. A., Merzouk, H., & Mokhtari-Soulimane, N. (2020). Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies. Plos One, 15(10), e0240653 https://doi.org/10.1371/journal.pone.0240653
   PubMed Web of Science ®Google Scholar
• Cortegiani, A., Ippolito, M., Ingoglia, G., & Einav, S. (2020). Chloroquine for COVID-19: Rationale, facts, hopes. Critical Care, 24(1), 210. https://doi.org/10.1186/s13054-020-02932-4
   PubMed Web of Science ®Google Scholar
• Cui, Q., Du, R., Anantpadma, M., Schafer, A., Hou, L., Tian, J., Davey, R. A., Cheng, H., & Rong, L. (2018). Identification of ellagic acid from plant Rhodiola rosea L. as an anti-Ebola virus entry inhibitor. Viruses, 10(4), 152. https://doi.org/10.3390/v10040152
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 42717. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Debnath, P. K., Banerjee, S., Debnath, P., Mitra, A., & Mukherjee, P. K. (2015). Ayurveda–opportunities for developing safe and effective treatment choices for the future. In P. K. Mukherjee (Ed.), Evidence-Based Validation of Herbal Medicine (pp. 427–454).
   Google Scholar
• Desforges, M., Le Coupanec, A., Dubeau, P., Bourgouin, A., Lajoie, L., Dubé, M., & Talbot, P. J. (2019). Human coronaviruses and other respiratory viruses: Underestimated opportunistic pathogens of the central nervous system? Viruses, 12(1), 14. Janhttps://doi.org/10.3390/v12010014
   PubMed Web of Science ®Google Scholar
• Devaux, C. A., Rolain, J. M., Colson, P., & Raoult, D. (2020). New insights on the antiviral effects of chloroquine against coronavirus: What to expect for COVID-19? International Journal of Antimicrobial Agents, 55(5), 105938. https://doi.org/10.1016/j.ijantimicag.2020.105938
   PubMed Web of Science ®Google Scholar
• Egan, W. J., Merz, K. M., & Baldwin, J. J. (2000). Prediction of drug absorption using multivariate statistics. Journal of Medicinal Chemistry, 43(21), 3867–3877. https://doi.org/10.1021/jm000292e
   PubMed Web of Science ®Google Scholar
• El-Mekkawy, S., Meselhy, M., Kusumoto, I., Kadota, S., Hattori, M., & Namba, T. (1995). Inhibitory effects of Egyptian folk medicines oh human immunodeficiency virus (HIV) reverse transcriptase. Chemical and Pharmaceutical Bulletin, 43(4), 641–648. https://doi.org/10.1248/cpb.43.641
   PubMed Web of Science ®Google Scholar
• Gandhi, A. J., Rupareliya, J. D., Shukla, V. J., Donga, S. B., & Acharya, R. (2020). An Ayurvedic perspective along with in silico study of the drugs for the management of SARS-CoV-2. Journal of Ayurveda and Integrative Medicine. https://doi.org/10.1016/j.jaim.2020.07.002
   Google Scholar
• Gentile, D., Patamia, V., Scala, A., Sciortino, M. T., Piperno, A., & Rescifina, A. (2020). Putative inhibitors of SARS-CoV-2 main protease from a library of marine natural products: A virtual screening and molecular modeling study. Marine Drugs, 18(4), 225. https://doi.org/10.3390/md18040225
   PubMed Web of Science ®Google Scholar
• Ghose, A. K., Viswanadhan, V. N., & Wendoloski, J. J. (1999). A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. Journal of Combinatorial Chemistry, 1(1), 55–68. https://doi.org/10.1021/cc9800071
   PubMedGoogle Scholar
• Grubaugh, N. D., Ladner, J. T., Lemey, P., Pybus, O. G., Rambaut, A., Holmes, E. C., & Andersen, K. G. (2019). Tracking virus outbreaks in the twenty-first century. Nature Microbiology, 4(1), 10–19. https://doi.org/10.1038/s41564-018-0296-2
   PubMed Web of Science ®Google Scholar
• Gupta, A., Ahmad, R., Siddiqui, S., Yadav, K., Srivastava, A., Trivedi, A., Ahmad, B., Khan, M. A., Shrivastava, A. K., & Singh, G. K. (2021). Flavonol morin targets host ACE2, IMP-α, PARP-1 and viral proteins of SARS-CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: A computational analysis. Journal of Biomolecular Structure and Dynamics, 1–32.
   Web of Science ®Google Scholar
• Guy, J. L., Jackson, R. M., Jensen, H. A., Hooper, N. M., & Turner, A. J. (2005). Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. The FEBS Journal, 272(14), 3512–3520. https://doi.org/10.1111/j.1742-4658.2005.04756.x
   PubMed Web of Science ®Google Scholar
• Hajivalili, M., Hosseini, M., & Haji-Fatahaliha, M. (2020). Gaining insights on immune responses to the novel coronavirus, COVID-19 and therapeutic challenges. Life Sciences, 257, 118058. https://doi.org/10.1016/j.lfs.2020.118058
   PubMed Web of Science ®Google Scholar
• Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271–280.e8. https://time.com/5954416/india-covid-second-wave/ https://doi.org/10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Jena, A. B., Kanungo, N., Nayak, V., Chainy, G. B. N., & Dandapat, J. (2021). Catechin and Curcumin interact with corona (2019-nCoV/SARS-CoV2) viral S protein and ACE2 of human cell membrane. Insights from Computational Study and Implication for Intervention. Scientific Reports. 11(1), 1 2043. https://doi.org/10.21203/rs.3.rs-22057/v1
   Google Scholar
• Kadioglu, O., Saeed, M., Greten, H. J., & Efferth, T. (2021). Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning. Computers in Biology and Medicine, 133, 104359. https://doi.org/10.1016/j.compbiomed.2021.104359
   PubMed Web of Science ®Google Scholar
• Kaihatsu, K., Yamabe, M., & Ebara, Y. (2018). Antiviral mechanism of action of epigallocatechin-3-O-gallate and its fatty acid esters. Molecules, 23(10), 2475. https://doi.org/10.3390/molecules23102475
   PubMed Web of Science ®Google Scholar
• Kar, P., Sharma, N. R., Singh, B., Sen, A., & Roy, A. (2020). Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation. Journal of Biomolecular Structure and Dynamics, 18, 1–2.
   Google Scholar
• Khan, S. A., & Al-Balushi, K. (2021). Combating COVID-19: The role of drug repurposing and medicinal plants. Journal of Infection and Public Health, 14(4), 495–503. https://doi.org/10.1016/j.jiph.2020.10.012
   PubMed Web of Science ®Google Scholar
• Khan, T., Azad, I., Ahmad, R., Raza, S., Dixit, S., Joshi, S., & Khan, A. R. (2018). Synthesis, characterization, computational studies and biological activity evaluation of Cu, Fe, Co and Zn complexes with 2-butanone thiosemicarbazone and 1,10-phenanthroline ligands as anticancer and antibacterial agents. EXCLI Journal, 17, 331–348. https://doi.org/10.17179/excli2017-984
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A. (2001). Avoiding investment in doomed drugs. Current Drug Discovery, 1, 17–19.
   Google Scholar
• Lovering, F., Bikker, J., & Humblet, C. (2009). Escape from flatland: Increasing saturation as an approach to improving clinical success. Journal of Medicinal Chemistry, 52(21), 6752–6756. https://doi.org/10.1021/jm901241e[Mismatch] [InsertedFromOnline
   PubMed Web of Science ®Google Scholar
• Manoharachary, C., & Nagaraju, D. (2016). Medicinal plants for human health and welfare. Annals of Phytomedicine, 5(1), 24–34.
   Web of Science ®Google Scholar
• Martin, Y. C. (2005). A bioavailability score. Journal of Medicinal Chemistry, 48(9), 3164–3170. https://doi.org/10.1021/jm0492002
   PubMed Web of Science ®Google Scholar
• Maurya, D. K., & Sharma, D. (2020). Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach. Journal of Biomolecular Structure and Dynamics, 1–16. https://doi.org/10.1080/07391102.2020.1852119
   Google Scholar
• Misra, A., Ahmad, R., Trivedi, A., & Khan, M. A. (2017). Evaluation of in vitro cytotoxic activity of ethanolic extract of Azadiracta indica leaves as a function of pH on human breast cancer cell line MDA-MB 231. Journal of Basic and Clinical Pharmacy, 8, S72–S79.
   Google Scholar
• Muegge, I., Heald, S. L., & Brittelli, D. (2001). Simple selection criteria for drug-like chemical matter. Journal of Medicinal Chemistry, 44(12), 1841–1846. https://doi.org/10.1021/jm015507e
   PubMed Web of Science ®Google Scholar
• Nadeem, M. K. (2020). In-silico study to elucidate corona virus by plant phytoderivatives that hits as a fusion inhibitor targeting HR1 domain in spike protein which conformational changes efficiently inhibit entry COVID-19. Translational Biomedicine, 11(3), 1.
   Google Scholar
• Namachivayam, B., Raj, J. S., & Kandakatla, N. (2014). 2D, 3D-QSAR, docking and optimization of 5-substituted-1H-Indazole as inhibitors of GSK3 β. International Journal of Pharmacy and Pharmaceutical Sciences, 6, 1–8.
   Google Scholar
• Orhan, I. E., & Deniz, F. S. (2020). Natural products as potential leads against coronaviruses: Could they be encouraging structural models against SARS-CoV-2? Natural Products and Bioprospecting, 10(4), 171–176. https://doi.org/10.1007/s13659-020-00250-4
   PubMed Web of Science ®Google Scholar
• Pandey, M. M., Rastogi, S., & Rawat, A. K. (2013). Indian traditional ayurvedic system of medicine and nutritional supplementation. Evidence-Based Complementary and Alternative Medicine, 2013, 1–12. doi: 10.1155/2013/376327
   Web of Science ®Google Scholar
• Pandey, P., Rane, J. S., Chatterjee, A., Kumar, A., Khan, R., Prakash, A., & Ray, S. (2020). Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: An in silico study for drug development. Journal of Biomolecular Structure and Dynamics, 1–11.
   PubMed Web of Science ®Google Scholar
• Pandit, M., & Latha, N. (2020). In silico studies reveal potential antiviral activity of phytochemicals from medicinal plants for the treatment of COVID-19 infection. https://doi.org/10.21203/rs.3.rs-22687/v1
   Google Scholar
• Parida, M. M., Upadhyay, C., Pandya, G., & Jana, A. M. (2002). Inhibitory potential of neem (Azadirachta indica Juss) leaves on dengue virus type-2 replication. Journal of Ethnopharmacology, 79(2), 273–278. https://doi.org/10.1016/s0378-8741(01)00395-6
   PubMed Web of Science ®Google Scholar
• Park, S. W., Kwon, M. J., Yoo, J. Y., Choi, H. J., & Ahn, Y. J. (2014). Antiviral activity and possible mode of action of ellagic acid identified in Lagerstroemia speciosa leaves toward human rhinoviruses. BMC Complementary and Alternative Medicine, 14(1), 171. https://doi.org/10.1186/1472-6882-14-171
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera-A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Potts, R. O., & Guy, R. H. (1992). Predicting skin permeability. Pharmaceutical Research, 09(5), 663–669. https://doi.org/10.1023/A:1015810312465
   Google Scholar
• Prasanth, D., Murahari, M., Chandramohan, V., Panda, S. P., Atmakuri, L. R., & Guntupalli, C. (2020). In silico identification of potential inhibitors from Cinnamon against main protease and spike glycoprotein of SARS CoV-2. Journal of Biomolecular Structure and Dynamics, 1–15.
   PubMedGoogle Scholar
• Proudfoot, J. R. (2002). Drugs, leads, and drug-likeness: An analysis of some recently launched drugs. Bioorganic & Medicinal Chemistry Letters, 12(12), 1647–1650. https://doi.org/10.1016/S0960-894X(02)00244-5
   PubMed Web of Science ®Google Scholar
• Purthvish, R., & Gopinatha, S. M. (2018). Antiviral prospective of Tinospora cordifolia on HSV-1. International Journal of Current Microbiology and Applied Sciences, 7(1), 3617–3624.
   Google Scholar
• Puttaswamy, H., Gowtham, H. G., Ojha, M. D., Yadav, A., Choudhir, G., Raguraman, V., Kongkham, B., Selvaraju, K., Shareef, S., Gehlot, P., Ahamed, F., & Chauhan, L. (2020). In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis. Scientific Reports, 10(1), 1–24. https://doi.org/10.1038/s41598-020-77602-0
   PubMed Web of Science ®Google Scholar
• Ramadan, N., & Shaib, H. (2019). Middle East respiratory syndrome coronavirus (MERS-CoV): A review. Germs, 9(1), 35–42. https://doi.org/10.18683/germs.2019.1155
   PubMedGoogle Scholar
• Reperant, L. A., Rimmelzwaan, G. F., & Kuiken, T. (2009). Avian influenza viruses in mammals. Revue Scientifique et Technique de l'OIE, 28(1), 137–159. https://doi.org/10.20506/rst.28.1.1876
   PubMed Web of Science ®Google Scholar
• Ritchie, T. J., Ertl, P., & Lewis, R. (2011). The graphical representation of ADME-related molecule properties for medicinal chemists. Drug Discovery Today, 16(1-2), 65–72. https://doi.org/10.1016/j.drudis.2010.11.002
   PubMed Web of Science ®Google Scholar
• Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. JAMA, 323(18), 1824–1836. https://doi.org/10.1001/jama.2020.6019
   PubMed Web of Science ®Google Scholar
• Sharma, R., Martins, N., Kuca, K., Chaudhary, A., Kabra, A., Rao, M. M., & Prajapati, P. K. (2019). Chyawanprash: A Traditional Indian Bioactive Health Supplement. Biomolecules, 9(5), 161. https://doi.org/10.3390/biom9050161
   PubMed Web of Science ®Google Scholar
• Shelat, A. A., & Guy, R. K. (2007). The interdependence between screening methods and screening libraries. Current Opinion in Chemical Biology, 11(3), 244–251. https://doi.org/10.1016/j.cbpa.2007.05.003
   PubMed Web of Science ®Google Scholar
• Siddiqui, S., Upadhyay, S., Ahmad, R., Gupta, A., Srivastava, A., Trivedi, A., Husain, I., Ahmad, B., Ahamed, M., & Khan, M. A. (2020). Virtual screening of phytoconstituents from miracle herb Nigella sativa targeting nucleocapsid protein and papain-like protease of SARS-CoV-2 for COVID-19 treatment. Journal of Biomolecular Structure and Dynamics, 1–21.
   Web of Science ®Google Scholar
• Singh, R., Gautam, A., Chandel, S., Ghosh, A., Dey, D., Roy, S., Ravichandiran, V., & Ghosh, D. (2020b). Protease inhibitory effect of natural polyphenolic compounds on SARS-CoV-2: An in silico study. Molecules, 25(20), 4604. https://doi.org/10.3390/molecules25204604
   PubMed Web of Science ®Google Scholar
• Singh, T. U., Parida, S., Lingaraju, M. C., Kesavan, M., Kumar, D., & Singh, R. K. (2020a). Drug repurposing approach to fight COVID-19. Pharmacological Reports : PR, 72(6), 1479–1508. https://doi.org/10.1007/s43440-020-00155-6
   PubMed Web of Science ®Google Scholar
• Srivastava, A., Siddiqui, S., Ahmad, R., Mehrotra, S., Ahmad, B. & Srivastava, A.N., (2020). Exploring nature’s bounty: Identification of Withania somnifera as a promising source of therapeutic agents against COVID-19 by virtual screening and in silico evaluation. Journal of Biomolecular Structure and Dynamics, 1–51.
   Web of Science ®Google Scholar
• Steinmann, J., Buer, J., Pietschmann, T., & Steinmann, E. (2013). Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. British Journal of Pharmacology, 168(5), 1059–1073. https://doi.org/10.1111/bph.12009
   PubMed Web of Science ®Google Scholar
• Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020). Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: Implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cellular & Molecular Immunology, 17(6), 613–620. https://doi.org/10.1038/s41423-020-0400-4
   PubMed Web of Science ®Google Scholar
• Thuy, B. T. P., My, T. T. A., Hai, N. T. T., Hieu, L. T., Hoa, T. T., Thi Phuong Loan, H., Triet, N. T., Anh, T. T. V., Quy, P. T., Tat, P. V., Hue, N. V., Quang, D. T., Trung, N. T., Tung, V. T., Huynh, L. K., & Nhung, N. T. A. (2020). Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil. ACS Omega, 5(14), 8312–8320. https://doi.org/10.1021/acsomega.0c00772
   PubMed Web of Science ®Google Scholar
• Tiwari, V., Beer, J. C., Sankaranarayanan, N. V., Swanson-Mungerson, M., & Desai, U. R. (2020). Discovering small-molecule therapeutics against SARS-CoV-2. Drug Discovery Today, 25(8), 1535–1544. https://doi.org/10.1016/j.drudis.2020.06.017
   PubMed Web of Science ®Google Scholar
• Touret, F., & de Lamballerie, X. (2020). Of chloroquine and COVID-19. Antiviral Research, 177, 104762. https://doi.org/10.1016/j.antiviral.2020.104762
   PubMed Web of Science ®Google Scholar
• Trivedi, A., Ahmad, R., & Misra, A. (2018). Effect of alkaline pH on cytotoxicity profile of neem (Azadirachta indica) ethanolic extract against human breast cancer cell line MDA-MB-231. European Journal of Integrative Medicine, 24, 1–7. 1https://doi.org/10.1016/j.eujim.2018.10.004
   Web of Science ®Google Scholar
• Trivedi, A., Fatima, N., Husain, I., & Misra, A. (2019). An update on the therapeutic potential of neem and its active constituents: A panacea for all diseases. Era's Journal of Medical Research, 6(1), 110–117. https://doi.org/10.24041/ejmr2019.116
   Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Ursu, O., Rayan, A., Goldblum, A., & Oprea, T. I. (2011). Understanding drug‐likeness. WIREs Computational Molecular Science, 1(5), 760–781. https://doi.org/10.1002/wcms.52
   Google Scholar
• Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/10.1021/jm020017n
   PubMed Web of Science ®Google Scholar
• Verma, A. (2012). Lead finding from Phyllanthus debelis with hepatoprotective potentials. Asian Pacific Journal of Tropical Biomedicine, 2(3), S1735–S7. https://doi.org/10.1016/S2221-1691(12)60486-9
   Google Scholar
• Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005). Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virology Journal, 2, 69. https://doi.org/10.1186/1743-422X-2-69
   PubMed Web of Science ®Google Scholar
• Wang, N., Shi, X., Jiang, L., Zhang, S., Wang, D., Tong, P., Guo, D., Fu, L., Cui, Y., Liu, X., Arledge, K. C., Chen, Y.-H., Zhang, L., & Wang, X. (2013). Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Research, 23(8), 986–993. https://doi.org/10.1038/cr.2013.92
   PubMed Web of Science ®Google Scholar
• Wang, C. Y., Hour, M. J., Lai, H. C., Chen, C. H., Chang, P. J., Huang, S. H., & Lin, C. W. (2018). Epigallocatechin-3-gallate inhibits the early stages of Japanese encephalitis virus infection. Virus Research, 253, 140–146. https://doi.org/10.1016/j.virusres.2018.06.009
   PubMed Web of Science ®Google Scholar
• Wang, Y., Wang, Y., Chen, Y., & Qin, Q. (2020). Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. Journal of Medical Virology, 92(6), 568–576. https://doi.org/10.1002/jmv.25748
   PubMed Web of Science ®Google Scholar
• Wu, D., Wu, T., Liu, Q., & Yang, Z. (2020). The SARS-CoV-2 outbreak: What we know. International Journal of Infectious Diseases : Diseases, 94, 44–48. https://doi.org/10.1016/j.ijid.2020.03.004
   PubMed Web of Science ®Google Scholar
• Yan, Y., Shin, W. I., Pang, Y. X., Meng, Y., Lai, J., You, C., Zhao, H., Lester, E., Wu, T., & Pang, C. H. (2020). The first 75 days of novel coronavirus (SARS-CoV-2) outbreak: Recent advances, prevention, and treatment. International Journal of Environmental Research and Public Health, 17(7), 2323. https://doi.org/10.3390/ijerph17072323
   PubMed Web of Science ®Google Scholar
• Yang, J. F., Wang, F., Chen, Y. Z., Hao, G. F., & Yang, G. F. (2020). LARMD: Integration of bioinformatic resources to profile ligand-driven protein dynamics with a case on the activation of estrogen receptor. Briefings in Bioinformatics, 21(6), 2206–2218. https://doi.org/10.1093/bib/bbz141
   PubMed Web of Science ®Google Scholar
• Yang, J. M., & Chen, C. C. (2004). GEMDOCK: A generic evolutionary method for molecular docking. Proteins, 55(2), 288–304. https://doi.org/10.1002/prot.20035
   PubMed Web of Science ®Google Scholar
• Zang, R., Gomez Castro, M. F., McCune, B. T., Zeng, Q., Rothlauf, P. W., Sonnek, N. M., Liu, Z., Brulois, K. F., Wang, X., Greenberg, H. B., Diamond, M. S., Ciorba, M. A., Whelan, S. P. J., & Ding, S. (2020). TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Science Immunology, 5(47), eabc3582. https://doi.org/10.1126/sciimmunol.abc3582
   PubMed Web of Science ®Google Scholar
• Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y.), 368(6489), 409–412. https://doi.org/10.1126/science.abb3405
   PubMed Web of Science ®Google Scholar
• Zhou, D., Dai, S. M., & Tong, Q. (2020). COVID-19: A recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. The Journal of Antimicrobial Chemotherapy, 75(7), 1667–1670. https://doi.org/10.1093/jac/dkaa114
   PubMed Web of Science ®Google Scholar